Combinations of conventional disease-modifying antirheumatic drugs

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

During the last decade, numerous new treatments and treatment approaches have literally transformed current thinking about rheumatoid arthritis (RA) and more, importantly, about the way patients are treated. The nearly universal acceptance of the use of combinations of disease-modifying antirheumatic drugs (DMARDs) to more effectively treat a growing percentage of patients with RA has been a central theme. Importantly controlled studies have no shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy.

Original languageEnglish (US)
Pages (from-to)415-426
Number of pages12
JournalRheumatic Disease Clinics of North America
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2001

Fingerprint

Antirheumatic Agents
Rheumatoid Arthritis
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Combinations of conventional disease-modifying antirheumatic drugs. / O'Dell, James Robert.

In: Rheumatic Disease Clinics of North America, Vol. 27, No. 2, 01.01.2001, p. 415-426.

Research output: Contribution to journalArticle

@article{b28c2a3b21eb4d58bd7f0c6f6548f909,
title = "Combinations of conventional disease-modifying antirheumatic drugs",
abstract = "During the last decade, numerous new treatments and treatment approaches have literally transformed current thinking about rheumatoid arthritis (RA) and more, importantly, about the way patients are treated. The nearly universal acceptance of the use of combinations of disease-modifying antirheumatic drugs (DMARDs) to more effectively treat a growing percentage of patients with RA has been a central theme. Importantly controlled studies have no shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy.",
author = "O'Dell, {James Robert}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0889-857X(05)70210-6",
language = "English (US)",
volume = "27",
pages = "415--426",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Combinations of conventional disease-modifying antirheumatic drugs

AU - O'Dell, James Robert

PY - 2001/1/1

Y1 - 2001/1/1

N2 - During the last decade, numerous new treatments and treatment approaches have literally transformed current thinking about rheumatoid arthritis (RA) and more, importantly, about the way patients are treated. The nearly universal acceptance of the use of combinations of disease-modifying antirheumatic drugs (DMARDs) to more effectively treat a growing percentage of patients with RA has been a central theme. Importantly controlled studies have no shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy.

AB - During the last decade, numerous new treatments and treatment approaches have literally transformed current thinking about rheumatoid arthritis (RA) and more, importantly, about the way patients are treated. The nearly universal acceptance of the use of combinations of disease-modifying antirheumatic drugs (DMARDs) to more effectively treat a growing percentage of patients with RA has been a central theme. Importantly controlled studies have no shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy.

UR - http://www.scopus.com/inward/record.url?scp=0035018899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035018899&partnerID=8YFLogxK

U2 - 10.1016/S0889-857X(05)70210-6

DO - 10.1016/S0889-857X(05)70210-6

M3 - Article

VL - 27

SP - 415

EP - 426

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -